David Bennett to Membrane Transport Proteins
This is a "connection" page, showing publications David Bennett has written about Membrane Transport Proteins.
Connection Strength
2.842
-
APOE e4-TOMM40 '523 haplotypes and the risk of Alzheimer's disease in older Caucasian and African Americans. PLoS One. 2017; 12(7):e0180356.
Score: 0.595
-
Neuropathologic features of TOMM40 '523 variant on late-life cognitive decline. Alzheimers Dement. 2017 Dec; 13(12):1380-1388.
Score: 0.592
-
TOMM40'523 variant and cognitive decline in older persons with APOE e3/3 genotype. Neurology. 2017 Feb 14; 88(7):661-668.
Score: 0.576
-
Association of Brain DNA methylation in SORL1, ABCA7, HLA-DRB5, SLC24A4, and BIN1 with pathological diagnosis of Alzheimer disease. JAMA Neurol. 2015 Jan; 72(1):15-24.
Score: 0.500
-
Novel Variance-Component TWAS method for studying complex human diseases with applications to Alzheimer's dementia. PLoS Genet. 2021 04; 17(4):e1009482.
Score: 0.193
-
TOMM40-APOE haplotypes are associated with cognitive decline in non-demented Blacks. Alzheimers Dement. 2021 08; 17(8):1287-1296.
Score: 0.191
-
The SORL1 gene and convergent neural risk for Alzheimer's disease across the human lifespan. Mol Psychiatry. 2014 Oct; 19(10):1125-32.
Score: 0.115
-
Preservation of nucleus basalis neurons containing choline acetyltransferase and the vesicular acetylcholine transporter in the elderly with mild cognitive impairment and early Alzheimer's disease. J Comp Neurol. 1999 Sep 06; 411(4):693-704.
Score: 0.043
-
Genetic epistasis regulates amyloid deposition in resilient aging. Alzheimers Dement. 2017 Oct; 13(10):1107-1116.
Score: 0.036